95 related articles for article (PubMed ID: 15528887)
1. Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.
Ramos MG; Rabelo FL; Brumatti G; Bueno-da-Silva AE; Amarante-Mendes GP; Alvarez-Leite JI
Chemotherapy; 2004 Nov; 50(5):221-8. PubMed ID: 15528887
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
3. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
Akiyama H; Ino T; Tokunaga E; Katsuda I; Ezaki K
Rinsho Byori; 2003 Aug; 51(8):733-9. PubMed ID: 13677932
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells.
dos Santos MP; Schwartsmann G; Roesler R; Brunetto AL; Abujamra AL
Leuk Res; 2009 Feb; 33(2):218-21. PubMed ID: 18692895
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
6. WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.
Wosikowski K; Mattern K; Schemainda I; Hasmann M; Rattel B; Löser R
Cancer Res; 2002 Feb; 62(4):1057-62. PubMed ID: 11861382
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
8. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
Bantel H; Engels IH; Voelter W; Schulze-Osthoff K; Wesselborg S
Cancer Res; 1999 May; 59(9):2083-90. PubMed ID: 10232592
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis.
Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD
Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3'-kinase inhibition in the KM20 human colon cancer cell line.
Wang Q; Li N; Wang X; Kim MM; Evers BM
Clin Cancer Res; 2002 Jun; 8(6):1940-7. PubMed ID: 12060639
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies on the inhibition of colon cancer by butyrate and carnitine.
Roy MJ; Dionne S; Marx G; Qureshi I; Sarma D; Levy E; Seidman EG
Nutrition; 2009; 25(11-12):1193-201. PubMed ID: 19619983
[TBL] [Abstract][Full Text] [Related]
12. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract][Full Text] [Related]
13. Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells.
Hui KP; Sit WH; Wan JM
Oncol Rep; 2005 Jul; 14(1):145-55. PubMed ID: 15944782
[TBL] [Abstract][Full Text] [Related]
14. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
15. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
16. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
17. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
18. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
[TBL] [Abstract][Full Text] [Related]
19. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
[TBL] [Abstract][Full Text] [Related]
20. Alterations in protein expression in HL-60 cells during etoposide-induced apoptosis modulated by the caspase inhibitor ZVAD.fmk.
Navakauskiene R; Treigyte G; Savickiene J; Gineitis A; Magnusson KE
Ann N Y Acad Sci; 2004 Dec; 1030():393-402. PubMed ID: 15659822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
